iPS Cell Differentiation for High-Yield Melanin Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for obtaining melanin from human skin or hair biopsies yield small, degraded amounts, and in vitro methods for producing pigmented cells are inefficient.
Innovation Solution
A method involving the differentiation of human induced pluripotent stem cells through a multi-step process, including formation of embryoid bodies, progenitor selection, and terminal differentiation in specific media conditions, to produce cells rich in melanin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If melanin is isolated from skin or hair biopsies, then melanin can be obtained, but the amounts are very small and in a highly degraded form
Solution Approach 1:
The invention segments the melanin production process into distinct stages: generating melanocyte progenitor cells from iPS cells, expanding these progenitors, and then inducing terminal differentiation to produce melanin. This segmentation allows each stage to be optimized independently, ensuring high-quality non-degraded melanin production while scaling up quantities.
Solution Approach 2:
The method performs preliminary actions by first generating and expanding melanocyte progenitor cells before inducing melanin production. This preliminary expansion phase ensures sufficient cell numbers are available for subsequent melanin generation, solving the quantity limitation while maintaining melanin quality through controlled differentiation.
2Productivity
If conventional in vitro methods are used to obtain pigmented cells, then cell production can be achieved, but the methods are extremely ineffective
Solution Approach 1:
The invention systematically changes multiple parameters throughout the differentiation process: medium composition (N1, N2, N3 with varying supplements and growth factors), substrate coatings (fibronectin, laminin, polyornithine), and chemical inducers (dibutyryl-cAMP, ascorbic acid). These parameter changes drive efficient progression through differentiation stages, achieving high productivity and yield of melanin-rich cells.
Solution Approach 2:
The method introduces intermediary cell types (melanocyte progenitor cells) that serve as intermediate stages between iPS cells and fully differentiated pigmented cells. These intermediaries facilitate efficient differentiation by providing a transitional state that responds to specific induction signals, greatly improving overall production efficiency.
3Reliability
If melanin is obtained from biopsies, then natural melanin can be acquired, but it requires invasive procedures and limited sources
Solution Approach 1:
The invention enables self-service by using iPS cells to generate their own melanocyte progenitors and subsequent pigmented cells without requiring external biopsy sources. The cells differentiate and produce melanin autonomously through the established protocol, making the source unlimited and eliminating invasive procedures while maintaining reliability.
Data Source
AI summary
The invention discloses the method of differentiating human induced Pluripotent Stem cells (iPS cells) to obtain pigmented cells which produce melanin. The protocol described is much more efficient than any other method used to obtain melanin in vitro.